JaiGrewalMD

Neurology • Osprey, FL

Neurooncology

Physician

Join to view full profile

Dr. Grewal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grewal's full profile

Already have an account?

Office
698 S Tamiami Trl
Osprey, FL 34229
Phone+1 941-432-6869

Fax+1 360-272-9368

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2005 - 2007
University of Texas Southwestern Medical CenterResidency, Neurology, 2002 - 2005
Griffin HospitalInternship, Internal Medicine, 2001 - 2002
Spartan Health Sciences UniversityClass of 2001

Certifications & Licensure

NY State Medical License 2007 - 2026
FL State Medical License 2005 - 2025
AZ State Medical License 2005 - 2008
UT State Medical License 2007 - 2008
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
Active, not recruiting
Phase 3
Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors Start of enrollment: 2008 Nov 01
Terminated
Phase 2
Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma Start of enrollment: 2008 Dec 01
Unknown status
Phase 2
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients Start of enrollment: 2012 Dec 01
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

166 citations
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A P...
Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim
JAMA Oncology. 2023-01-01
195 citations
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29
60 citations
Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the...
Matthew T. Ballo, Noa Urman, Gitit Lavy-Shahaf, Jai Grewal, Zeev Bomzon
International Journal of Radiation Oncology, Biology, Physics. 2019-08-01

Press Mentions

Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
Dr. Volker W. Stieber, MD, Joins Vivacitas' Neuro-Oncology Advisory BoardFebruary 7th, 2022

Other Languages

Spanish